These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22326287)

  • 1. Knowledge engineering for adverse drug event prevention: on the design and development of a uniform, contextualized and sustainable knowledge-based framework.
    Koutkias V; Kilintzis V; Stalidis G; Lazou K; Niès J; Durand-Texte L; McNair P; Beuscart R; Maglaveras N
    J Biomed Inform; 2012 Jun; 45(3):495-506. PubMed ID: 22326287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a standardised representation of a knowledge base for adverse drug event prevention.
    Koutkias V; Lazou K; de Clercq P; Maglaveras N
    Stud Health Technol Inform; 2011; 166():139-47. PubMed ID: 21685619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A knowledge engineering framework towards clinical support for adverse drug event prevention: the PSIP approach.
    Koutkias V; Stalidis G; Chouvarda I; Lazou K; Kilintzis V; Maglaveras N
    Stud Health Technol Inform; 2009; 148():131-41. PubMed ID: 19745243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three different cases of exploiting decision support services for adverse drug event prevention.
    Bernonille S; Nies J; Pedersen HG; Guillot B; Maazi M; Berg AL; Sarfati JC; Koutkias V
    Stud Health Technol Inform; 2011; 166():180-8. PubMed ID: 21685623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug event prevention in neonatal care: a rule-based approach.
    Lazou K; Farini M; Koutkias V; Drossou V; Maglaveras N; Bassiliades N
    Stud Health Technol Inform; 2013; 186():170-4. PubMed ID: 23542991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of completeness, correctness, relevance and understandability of the PSIP CDSS for medication safety.
    Ammenwerth E; Hackl WO; Massari P; Darmoni S
    Stud Health Technol Inform; 2011; 166():254-9. PubMed ID: 21685631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information contextualization in decision support modules for adverse drug event prevention.
    Nies J; Koutkias V; Kilintzis V; Guillot B; Maglaveras N; Pedersen HG; Berg AL; Skjoet P
    Stud Health Technol Inform; 2011; 166():95-104. PubMed ID: 21685615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient safety through intelligent procedures in medication: the PSIP project.
    Beuscart R; McNair P; Brender J;
    Stud Health Technol Inform; 2009; 148():6-13. PubMed ID: 19745230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design and application of medical knowledge model on SAGE].
    Yang Y; Wu BF; Ye F; Lv XD
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Jan; 33(1):27-30. PubMed ID: 19459347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing Clinical Decision Support Systems for Adverse Drug Event Prevention: A Knowledge-based Approach.
    Koutkias V; Kilintzis V; Stalidis G; Lazou K; Collyda C; Chazard E; McNair P; Beuscart R; Maglaveras N
    AMIA Annu Symp Proc; 2010 Nov; 2010():402-6. PubMed ID: 21347009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication related computerized decision support system (CDSS): make it a clinicians' partner!
    Marcilly R; Leroy N; Luyckx M; Pelayo S; Riccioli C; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():84-94. PubMed ID: 21685614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inevitable components of and steps for ADE management systems: the need for a Unified Ontological Framework (UOF) and a more effective collaboration in medication safety.
    Eryilmaz EN; Dündar G; Sari SO
    Stud Health Technol Inform; 2009; 148():149-58. PubMed ID: 19745245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistics-based approach of contextualization for adverse drug events detection and prevention.
    Chazard E; Bernonville S; Ficheur G; Beuscart R
    Stud Health Technol Inform; 2012; 180():766-70. PubMed ID: 22874295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using ontologies for structuring organizational knowledge in Home Care assistance.
    Valls A; Gibert K; Sánchez D; Batet M
    Int J Med Inform; 2010 May; 79(5):370-87. PubMed ID: 20185360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formalization of clinical practice guidelines.
    Buchtela D; Peleska J; Veselý A; Zvárová J; Zvolský M
    Stud Health Technol Inform; 2008; 136():151-6. PubMed ID: 18487723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling and acquisition of drug-drug interaction knowledge.
    Mille F; Degoulet P; Jaulent MC
    Stud Health Technol Inform; 2007; 129(Pt 2):900-4. PubMed ID: 17911846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug knowledge expressed as computable semantic triples.
    Elkin PL; Carter JS; Nabar M; Tuttle M; Lincoln M; Brown SH
    Stud Health Technol Inform; 2011; 166():38-47. PubMed ID: 21685609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.